Veronica Powell
Family · Milwaukee, WINPI 1811552623
Payments from drug & device makers
Across 31 payments — averaging $20.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Almatica Pharma LLC$221
- Teva Pharmaceuticals USA, Inc.$134
- Johnson & Johnson$50
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$45
- Axsome Therapeutics, Inc.$33
- Lundbeck LLC$32
- plus $113 from 6 others
What the payments were for
- Food & beverage$51782%
- Education$11118%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Almatica Pharma LLC | 15 | $221 |
| Teva Pharmaceuticals USA, Inc. | 2 | $134 |
| Johnson & Johnson | 2 | $50 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Lundbeck LLC | 1 | $32 |
| AbbVie | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Alkermes, Inc. | 1 | $22 |
| Neurocrine Biosciences, Inc. | 1 | $21 |
| Tris Pharma Inc | 1 | $15 |
| Corium, LLC | 2 | $9 |
How this compares
$629 in reported general payments places this provider in the 75th percentile of 1,273 family providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 56 | $157,558 |
| VraylarCariprazine Hcl | 64 | $96,885 |
| RexultiBrexpiprazole | 29 | $39,040 |
| CaplytaLumateperone Tosylate | 14 | $23,600 |
| VyvanseLisdexamfetamine Dimesylate | 21 | $10,447 |
| Olanzapine | 178 | $7,699 |
| Paliperidone ErPaliperidone | 31 | $6,411 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 31 | $5,232 |
| BelsomraSuvorexant | 11 | $4,920 |
| Aripiprazole | 69 | $4,816 |
| Divalproex Sodium | 59 | $3,330 |
| Quetiapine Fumarate | 186 | $2,595 |
| Ziprasidone Hcl | 29 | $2,533 |
| Trazodone Hcl | 248 | $2,205 |
| Divalproex Sodium ErDivalproex Sodium | 47 | $2,198 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $50 | $157,55856 claims |
| AbbVieVraylar | $24 | $96,88564 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $45 | $23,60014 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $23 | $10,44721 claims |
| Almatica Pharma LLCSertraline Hcl | $221 | $1,139162 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,273 family providers in Wisconsin.
Other family in Milwaukee
- Stephanie OffordMilwaukee$763K
- Tracy NelsonMilwaukee$24K
- Sarah EmmerichMilwaukee$15K
- Erin LassanskeMilwaukee$14K
- Katrina BaxterMilwaukee$13K
- Natalie KerberMilwaukee$12K
- Jenta AlexanderMilwaukee$12K
- Lileta WintMilwaukee$10K
- Mary Jane de JesusMilwaukee$10K
- Kelley BeltranMilwaukee$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.